Detalhe da pesquisa
1.
Differences in integrated assessment and management of non-communicable diseases (NCDs) for people with HIV across the WHO European region.
HIV Med
; 25(6): 700-710, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38361216
2.
Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
Clin Infect Dis
; 71(5): 1263-1268, 2020 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-31563938
3.
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
BMC Infect Dis
; 20(1): 30, 2020 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31924172
4.
Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program.
Hepatol Res
; 48(1): 36-44, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28258606
5.
The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia.
Virol J
; 13: 22, 2016 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-26843145
6.
The Management of Patients at High Risk of Serious COVID-19 Disease: Optimising the Patient Pathway in the Middle East, Africa, and Eastern Europe.
Cureus
; 16(5): e60727, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38779436
7.
Effect of remdesivir on mortality and the need for mechanical ventilation among hospitalized patients with COVID-19: real-world data from a resource-limited country.
Int J Infect Dis
; 129: 63-69, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36690139
8.
Characterization of HIV-1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia.
J Med Virol
; 84(7): 1002-8, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22585715
9.
Treatment of hepatitis C in primary health care in the country of Georgia.
Clin Liver Dis (Hoboken)
; 20(5): 175-178, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36447909
10.
Prevention of mother-to-child transmission of HIV: the Georgian experience.
Cent Eur J Public Health
; 16(3): 128-33, 2008 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-18935779
11.
Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
Eur J Gastroenterol Hepatol
; 29(11): 1223-1230, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28857900
12.
Late presentation of HIV infection in the country of Georgia: 2012-2015.
PLoS One
; 12(10): e0186835, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29084276
13.
Progress Toward Achieving the UNAIDS 90-90-90 Goals in HIV Care From Diagnosis to Durable Viral Suppression in the Country of Georgia.
AIDS Res Hum Retroviruses
; 33(10): 999-1003, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28051324
14.
Significant Improvements Are Needed in HIV Care Continuum to Meet 90-90-90 Targets in Georgia.
J Int Assoc Provid AIDS Care
; 15(6): 451-454, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27629869
15.
Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia.
Int J STD AIDS
; 30(12): 1185-1193, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31558133
16.
Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia.
AIDS Res Treat
; 2011: 621078, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21490781